Trials / Completed
CompletedNCT04941001
Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)
Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS) in Primary Care Using a Digital Consultation Tool During the COVID-19 Pandemic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 202 (actual)
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
A digital tool, called ReferID has been developed to facilitate the review of asthma patients. It aims to assist in the identification of patients with uncontrolled and/or severe asthma and to ensure a timely referral to secondary care where appropriate. To validate the tool, patients will be randomised to have a review with a healthcare professional using tool to facilitate the review or to continue receiving usual care. Outcome measures including exacerbation frequency and level of asthma control will be assessed at 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ReferID | The ReferID tool is a digital tool which can be used to facilitate a review of asthma in primary care |
Timeline
- Start date
- 2021-08-09
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2021-06-28
- Last updated
- 2023-08-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04941001. Inclusion in this directory is not an endorsement.